Riskpilot← Back to searchSign inGet full accessREVMATISMESYKEHUSET AS
ASActiveOrg 985773238Margrethe Grundtvigs Veg 6, 2609 LillehammerHospital activities · NACE 8610Est. 2003106 employeeswww.revmatismesykehuset.no
Revenue 2024
NOK 110,7M
+7% vs 2023
EBITDA margin
-0.5%
-114% vs 2023
Equity ratio
76.7%
Financial strength
Net profit 2024
NOK -1,8M
-168% vs 2023
| Revenue | NOK 110,7M | +7% |
| EBITDA | NOK -512K | -114% |
| Net profit | NOK -1,8M | -168% |
| Total assets | NOK 93,9M | -2% |
| Equity | NOK 72M | -2% |
| Employees | 106 | — |
Legal name
REVMATISMESYKEHUSET AS
Org number
985773238
Legal form
Aksjeselskap
NACE code
8610 · Hospital activities
Founded
16. juni 2003
Share capital
NOK 5 100 000
Employees
106 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Selskapets formål er sykehusdrift. Sykehusets formål er å gi pasienter med revmatiske sykdommer optimale tilbud innenfor diagnostikk, medisinsk behandling, rehabilitering og undervisning. Sykehuset skal også delta aktivt i nasjonal og internasjonal forskning.
Address
Margrethe Grundtvigs Veg 6, 2609 Lillehammer
Phone
+4761279500
Email
post@revmatismesykehuset.no
Website
www.revmatismesykehuset.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 91 163 | 98 470 | 97 532 | 103 623 | 110 707 |
| Staff expenses | −67 642 | −76 267 | −74 171 | −79 675 | −87 207 |
| EBITDA | 7 179 | 3 704 | 4 155 | 3 533 | −512 |
| Depreciation & amort. | −2 992 | −2 712 | −2 442 | −2 604 | −2 685 |
| EBIT | 4 187 | 992 | 1 712 | 930 | −3 198 |
| Net financials | 593 | 393 | 895 | 1 724 | 1 398 |
| Profit before tax | 4 780 | 1 386 | 2 608 | 2 653 | −1 800 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 4 780 | 1 386 | 0 | 2 653 | −1 800 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 102 703 | 103 701 | 99 324 | 95 603 | 93 909 |
| Equity | 66 572 | 68 403 | 70 583 | 73 798 | 71 998 |
| Long-term debt | −4 680 | −5 020 | −3 324 | 2 903 | 2 823 |
| Short-term debt | 27 722 | 27 007 | 21 952 | 18 902 | 19 087 |
| Total debt | 31 300 | 30 144 | 24 855 | 21 805 | 21 910 |
EBITDA margin
-0.5%
This company
15.8%
Market median
-103% vs market
20202024
Equity ratio
76.7%
This company
38.2%
Market median
+101% vs market
20202024
Return on equity
-2.5%
This company
18.4%
Market median
-114% vs market
20202024
Net profit margin
-1.6%
This company
8.1%
Market median
-120% vs market
20202024
Asset turnover
1.18×
This company
1.12×
Market median
+5% vs market
20202024
Debt / equity
0.30×
This company
0.62×
Market median
+52% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
TF Deputy Member | Deputy Member | 2022 |
AA Deputy Member | Deputy Member | 2024 |
AS Chief Executive Officer | Chief Executive Officer | 2022 |
| Former (3) | ||
BP Chief Executive Officer | Chief Executive Officer | 2019 – 2022 |
EA Deputy Member | Deputy Member | 2022 – 2024 |
HM Chief Executive Officer | Chief Executive Officer | 2022 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (6) | ||
| Deputy Chairman | 2022 | |
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Chairman | 2022 | |
| Former (2) | ||
| Board of Directors | 2021 – 2022 | |
| Board of Directors | 2021 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of REVMATISMESYKEHUSET AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Benedikt Philipp Wetzel | Chief Executive Officer | 0 companies |
| Tamara Fawzi Pettersson | Deputy Member | 0 companies |
| Anne Aslaug Svarstad | Deputy Member | 0 companies |
| Atle Sørensen | Chief Executive Officer | 0 companies |
| Eva Anette Gryttingslien Thorsen | Deputy Member | 0 companies |
| Harald Moen | Chief Executive Officer | 0 companies |
| Synnøve Brenden | Deputy Chairman | 0 companies |
| Nicolai Løland Dolva | Board of Directors | 0 companies |
| Cecilie Holm Moldegård | Board of Directors | 0 companies |
| Sigrid Lindvik | Board of Directors | 0 companies |
| Heidi Helleberg Kverneggen Øvreås | Board of Directors | 0 companies |
| Gunhild Margrethe Blegen | Board of Directors | 0 companies |
| Sølvi Sofienlund Lundgaard | Board of Directors | 0 companies |
| Rolf Stalenget | Chairman | 0 companies |